Uncategorized

Anthropic pays $400M for biotech; Praxis epilepsy drug hits in Phase 1/2 trial

Published

on

Plus: Debt financing deals for Apnimed and Opus Genetics

Anthropic buys a stealth biotech: The San Francisco artificial intelligence giant is buying Coefficient Bio, building out its plans to bring AI into life sciences. Anthropic …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version